ELYM - LPCN ADIL and CADL among pre-market losers
2024-04-12 08:32:45 ET
More on Pre-market losers & stocks.
- Candel Therapeutics receives FDA orphan drug designation for its pancreatic cancer treatment
- Adial stock rallies 81% on data for alcohol abuse drug
- Seeking Alpha’s Quant Rating on Adial Pharmaceuticals
- Historical earnings data for Adial Pharmaceuticals
- Financial information for Adial Pharmaceuticals